Evidence map›Paper›PMID 26784696›Full record

ArticlePloS one2016

Ligation of Glycophorin A Generates Reactive Oxygen Species Leading to Decreased Red Blood Cell Function.

Joseph Khoory, Jessica Estanislau, Abdallah Elkhal, Asmae Lazaar, Mark I Melhorn, Abigail Brodsky, Ben Illigens, Itaru Hamachi, Yasutaka Kurishita, Alexander R Ivanov and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  10. Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  11. Review
  12. Article
  13. Drug delivery by erythrocytes: "Primum non nocere".Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2016
    Review
  14. Global transformation of erythrocyte properties via engagement of an SH2-like sequence in band 3.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Joseph KhooryDivision of Allergy and Inflammation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States of America.
Jessica EstanislauDivision of Allergy and Inflammation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States of America.
Abdallah ElkhalDepartment of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America.
Asmae LazaarDivision of Allergy and Inflammation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States of America.
Mark I MelhornDivision of Allergy and Inflammation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States of America.
Abigail BrodskyDivision of Allergy and Inflammation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States of America.
Ben IlligensDepartment of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States of America.
Itaru HamachiDepartment of Synthetic Chemistry & Biological Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Kyoto, Japan.
Yasutaka KurishitaDepartment of Synthetic Chemistry & Biological Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Kyoto, Japan.
Alexander R IvanovThe Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, United States of America.
Sergey ShevkoplyasDepartment of Biomedical Engineering, Cullen College of Engineering, University of Houston, Houston, United States of America.
Nathan I ShapiroDepartment of Emergency Medicine and Center for Vascular Biology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States of America.
Ionita C GhiranDivision of Allergy and Inflammation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States of America.
Beth Israel Deaconess Medical Center · USHarvard University · USKyoto Katsura Hospital · JPKyoto University · JPNortheastern University · USUniversity of Houston · US

Funding

Modulation of erythrocyte function by complementR01HL096795 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GHIRAN, IONITA CALIN · 2011 to 2014
$1.7M
NHLBI NIH HHS R01 HL096795
6 · The paper itself

Abstract

Acute, inflammatory conditions associated with dysregulated complement activation are characterized by significant increases in blood concentration of reactive oxygen species (ROS) and ATP. The mechanisms by which these molecules arise are not fully understood. In this study, using luminometric- and fluorescence-based methods, we show that ligation of glycophorin A (GPA) on human red blood cells (RBCs) results in a 2.1-fold, NADPH-oxidase-dependent increase in intracellular ROS that, in turn, trigger multiple downstream cascades leading to caspase-3 activation, ATP release, and increased band 3 phosphorylation. Functionally, using 2D microchannels to assess membrane deformability, GPS-ligated RBCs travel 33% slower than control RBCs, and lipid mobility was hindered by 10% using fluorescence recovery after photobleaching (FRAP). These outcomes were preventable by pretreating RBCs with cell-permeable ROS scavenger glutathione monoethyl ester (GSH-ME). Our results obtained in vitro using anti-GPA antibodies were validated using complement-altered RBCs isolated from control and septic patients. Our results suggest that during inflammatory conditions, circulating RBCs significantly contribute to capillary flow dysfunctions, and constitute an important but overlooked source of intravascular ROS and ATP, both critical mediators responsible for endothelial cell activation, microcirculation impairment, platelet activation, as well as long-term dysregulated adaptive and innate immune responses.

Indexed as

Adenosine TriphosphateAnion Exchange Protein 1, ErythrocyteCaspase 3Erythrocyte MembraneErythrocytesGlycophorinsHumansLipid MetabolismOxidation-ReductionPhenotypePhosphorylationrac1 GTP-Binding ProteinReactive Oxygen SpeciesAdenosine TriphosphateAnion Exchange Protein 1, ErythrocyteCaspase 3Glycophorinsrac1 GTP-Binding ProteinReactive Oxygen Species

Identifiers

PMID26784696
PMCPMC4718526
OpenAlexW2340656129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.